Bespoke Extracts (BSPK) EBIT Growth (5y) (2016 - 2021)
Bespoke Extracts (BSPK) EBIT Growth (5y) (2016 - 2021) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Bespoke Extracts | 1.12 Mn | 1.11 Mn | 234,175.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2021 | -10.27% |
| Aug 31, 2021 | 123.25% |
| May 31, 2021 | -34.05% |
| Feb 28, 2021 | -11.05% |
| Nov 30, 2020 | -20.04% |
| May 31, 2020 | -120.29% |
| Feb 29, 2020 | -26.85% |
| Nov 30, 2019 | -49.88% |
| Aug 31, 2019 | -24.95% |
| May 31, 2019 | -30.44% |
| Feb 28, 2019 | -20.05% |
| Nov 30, 2018 | 117.50% |
| Aug 31, 2018 | -96.12% |
| May 31, 2018 | -104.93% |
| Feb 28, 2018 | -81.73% |
| Nov 30, 2017 | -60.21% |
| May 31, 2017 | -83.86% |
| Feb 28, 2017 | 23.23% |
| Nov 30, 2016 | 31.79% |